Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

Author(s): Demidem, A., Lam, T. , Alas, S. , Hariharan, K. , Hanna, N. , Bonavida, B.

Journal/Book: cancer biother radiopharmaceuticals. 1997; 12(3): 177-186.

Note: copy

Keyword(s): krebs gf